| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |